
Aktiekursudvikling
WntResearch: Closer Than Ever
Case: WntResearch Closer than ever WntResearch has applied for their phase II trials regarding proof-of-concept for the FOXT-5 compound. Hence, WntResearch is closer than ever
Case: WntResearch Closer than ever WntResearch has applied for their phase II trials regarding proof-of-concept for the FOXT-5 compound. Hence, WntResearch is closer than ever
Jernbanegade 4, 3. th
1608 København V
CVR: 37364843
Telefon: +45 8988 7846
E-mail: info@kapitalpartner.dk
Kapital Partner udfører eller har inden for de seneste 12 måneder udført corporate finance, market relations, investor relations, Certified Adviser eller andre rådgivningsaktiviteter for følgende børsnoterede selskaber: Biosergen, InterMail, Pila Pharma, Hypefactors, Curasight, Evaxion, Re-Match, Audientes, Mdundo.com, Nexcom.